These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1320089)

  • 1. [Idiopathic hyperaldosteronism and the related dexamethasone suppressive hyperaldosteronism].
    Yasuda K; Miura K
    Nihon Naika Gakkai Zasshi; 1992 Apr; 81(4):517-22. PubMed ID: 1320089
    [No Abstract]   [Full Text] [Related]  

  • 2. Anomalous postural aldosterone response in glucocorticoid-suppressible hyperaldosteronism.
    Ganguly A; Grim CE; Weinberger MH
    N Engl J Med; 1981 Oct; 305(17):991-3. PubMed ID: 6268979
    [No Abstract]   [Full Text] [Related]  

  • 3. Dexamethasone suppressible hyperaldosteronism: insights into adrenal physiology.
    Connell JM; Jardine A; Fraser R
    Adv Nephrol Necker Hosp; 1990; 19():69-77. PubMed ID: 2154082
    [No Abstract]   [Full Text] [Related]  

  • 4. Angiotensin-responsive aldosterone-producing adenoma masquerades as idiopathic hyperaldosteronism (IHA: adrenal hyperplasia) or low-renin essential hypertension.
    Gordon RD; Gomez-Sanchez CE; Hamlet SM; Tunny TJ; Klemm SA
    J Hypertens Suppl; 1987 Dec; 5(5):S103-6. PubMed ID: 2832571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Renin-angiotensin-aldosterone function tests].
    Haruyama K; Fukuchi S
    Nihon Rinsho; 1982; 40(9):1997-2002. PubMed ID: 6296488
    [No Abstract]   [Full Text] [Related]  

  • 6. Aldosterone production after suppression of corticotropic secretory activity.
    Spark RF; Gordon SJ; Dale SL; Melby JC
    Arch Intern Med; 1968 Nov; 122(5):394-8. PubMed ID: 4301259
    [No Abstract]   [Full Text] [Related]  

  • 7. [Primary dexamethasone-suppressible hyperaldosteronism and hyperprolactinemia].
    Veglio F; Pinna G; Rabbia F; Mulatero P; Chiandussi L
    Minerva Endocrinol; 1992; 17(1):43-6. PubMed ID: 1323053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of aldosterone secretion by the renin-angiotensin system and by corticotropin.
    Gross F
    Adv Intern Med; 1968; 14():281-339. PubMed ID: 4303034
    [No Abstract]   [Full Text] [Related]  

  • 9. Glucocorticoid-suppressible hyperaldosteronism: a clue to the missing hormone?
    Mulrow PJ
    N Engl J Med; 1981 Oct; 305(17):1012-4. PubMed ID: 6268977
    [No Abstract]   [Full Text] [Related]  

  • 10. Idiopathic hyperaldosteronism. A possible role for aldosterone-stimulating factor.
    Carey RM; Sen S; Dolan LM; Malchoff CD; Bumpus FM
    N Engl J Med; 1984 Jul; 311(2):94-100. PubMed ID: 6330549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of ACTH in the episodic release of aldosterone in patients with idiopathic adrenal hyperplasia, hypertension, and hyperaldosteronism.
    Kem DC; Weinberger MH; Gomez-Sanchez C; Higgins JR; Kramer NJ
    J Lab Clin Med; 1976 Aug; 88(2):261-70. PubMed ID: 182890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idiopathic hyperaldosteronism in a dog.
    Breitschwerdt EB; Meuten DJ; Greenfield CL; Anson LW; Cook CS; Fulghum RE
    J Am Vet Med Assoc; 1985 Oct; 187(8):841-5. PubMed ID: 2997095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normotensive glucocorticoid-suppressible hyperaldosteronism in adult.
    Maeda T; Ashie T; Kikuiri K; Takakura M; Hikita N; Nakagawa H; Shimamoto K
    Endocrinol Jpn; 1989 Dec; 36(6):817-25. PubMed ID: 2633910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial, dexamethasone-suppressible, normokalemic hyperaldosteronism.
    Grim CE; Weinberger MH
    Pediatrics; 1980 Mar; 65(3):597-604. PubMed ID: 6987607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current diagnosis and treatment of primary aldosteronism.
    Kaplan NM
    Expert Rev Cardiovasc Ther; 2010 Nov; 8(11):1527-30. PubMed ID: 21090927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hyperaldosteronism and the renin-angiotensin system].
    Torikai T; Maebashi M; Yoshinaga K; Katsushima I; Goto K
    Saishin Igaku; 1969 May; 24(5):1048-54. PubMed ID: 4309762
    [No Abstract]   [Full Text] [Related]  

  • 17. Dexamethasone-suppressible hyperaldosteronism: a large new kindred.
    O'Mahony S; Burns A; Murnaghan DJ
    J Hum Hypertens; 1989 Aug; 3(4):255-8. PubMed ID: 2552113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Major endocrine diseases].
    Kato T
    Nihon Rinsho; 1982; 40(9):2041-7. PubMed ID: 6296489
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hypoaldosteronism].
    Villabona C; Pallares R; Capell S; Busquets E
    Rev Clin Esp; 1983 Feb; 168(4):221-8. PubMed ID: 6304822
    [No Abstract]   [Full Text] [Related]  

  • 20. Pathophysiological roles of the adrenal renin-angiotensin system in patients with primary aldosteronism.
    Oda N; Takeda Y; Zhu A; Usukura M; Yoneda T; Takata H; Mabuchi H
    Hypertens Res; 2006 Jan; 29(1):9-14. PubMed ID: 16715648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.